Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized trial of glucocorticoids for anti-interferon-gamma autoantibody syndrome
ChiCTR2400079820Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Anti-interferon-gamma autoantibody syndrome (AIGA) comparing oral prednisone acetate with Control: oral placebo (2 arms). Primary endpoint: Anti-interferon-gamma autoantibody level. Started Jan 2024; status: recruiting.
02
Drugs
prednisone
03
Conditions
Anti-interferon-gamma autoantibody syndrome (AIGA)
Beyond the preview
Go deeper on ChiCTR2400079820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079820.